<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03089450</url>
  </required_header>
  <id_info>
    <org_study_id>CG-DE-225-008</org_study_id>
    <nct_id>NCT03089450</nct_id>
  </id_info>
  <brief_title>To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent</brief_title>
  <official_title>A Multicenter, Subject-blinded, Randomized Study to Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent in Patients Undergoing Drug-eluting Stent Procedure After Coronary Angiography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CGBio Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CGBio Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      to evaluate safety and efficacy of CGBIO stent(DES) compared to Biomatrix flex stent(DES)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A Multicenter, subject-blinded, randomized study to evaluate safety and efficacy of CGBIO
      stent compared to Biomatrix Flex stent in patients undergoing drug-eluting stent procedure
      after coronary angiography
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 22, 2017</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>in-segment late loss</measure>
    <time_frame>9 month</time_frame>
    <description>angiographic in-segment late loss measure by QCA program</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>in-stent late loss</measure>
    <time_frame>9 month</time_frame>
    <description>angiographic in-stent late loss measure by QCA program</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACE</measure>
    <time_frame>9 month</time_frame>
    <description>death, MI and TVF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Restenosis rate</measure>
    <time_frame>9month</time_frame>
    <description>angiographic restenosis rate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Ischemic Heart Disease</condition>
  <condition>Stable Coronary Artery Disease</condition>
  <condition>Stable Angina</condition>
  <condition>Unstable Angina</condition>
  <condition>NSTEMI - Non-ST Segment Elevation MI</condition>
  <arm_group>
    <arm_group_label>CGBIO stent (DES)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Co-Cr biodegradable polymer DES Sirolimus DRUG Ascorbic Acid(Vitamin C)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Biomatrix flex(DES)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The abluminal biodegradable polymer DES BA9™ (BIOLIMUS A9™) DRUG</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CGBio stent</intervention_name>
    <description>Percutaneous Coronary Intervention</description>
    <arm_group_label>CGBIO stent (DES)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biomatrix flex</intervention_name>
    <description>Percutaneous Coronary Intervention</description>
    <arm_group_label>Biomatrix flex(DES)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least one lesion with a diameter stenosis &gt;50%

          -  suitable for coronary stent implantation in a vessel with a reference diameter ranging
             from 2.5 mm to 4.0 mm;

          -  Gr 1 ≤TIMI flow

        Exclusion Criteria:

          -  ST-segment elevation MI

          -  Bifurcation lesion

          -  Chronic total occulusion

          -  Restenosis lesion

          -  Graft vessel lesion

          -  Patient has a history of bleeding diathesis or coagulopathy or patients in whom
             anti-platelet and/or anticoagulant therapy is contraindicated or in which patient will
             not be able to comply with dual antiplatelet therapy for at least 1 year

          -  Cardiogenic shock or hemodynamic compromise

          -  Existing impairment in liver and kidney.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hyo-Soo KIim, MD/PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Soeoul national university hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Young-Hyo Lim, MD/PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hanyang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Junghan Yoon, MD/PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wonju Severance Christian Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hyo-Soo KIim, MD/PhD</last_name>
    <phone>+82-2-2072-2226</phone>
    <email>usahyosoo@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Soeul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyo-Soo Kim, MD/PhD</last_name>
      <phone>+82-2-2072-2226</phone>
      <email>usahyosoo@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Eunkyung Lee</last_name>
      <phone>+82 2-2072-4034</phone>
      <email>yordim.lee@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2017</study_first_submitted>
  <study_first_submitted_qc>March 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2017</study_first_posted>
  <last_update_submitted>March 26, 2017</last_update_submitted>
  <last_update_submitted_qc>March 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Angina, Stable</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

